Mirxes IPO Trading Update
Duality Biotherapeutics raises $140m in global offering, set to list on Hong Kong Stock Exchange with highly concentrated free float shares.
556 Views
Pre-IPO Mirxes Holding (PHIP Updates) - Some Points Worth the Attention
GASTROClear faces limited clinical application due to lack of recognition,leading to lower-than-expected penetration.IPO pricing is expensive.We...
674 Views
Mirxes IPO: Valuation Without Sensible Fundamentals
Singapore biotech company Mirexes launches IPO in Hong Kong to raise up to $139m, but little fundamentals support the valuation, even in blue sky...
1.1k Views
Mirxes Pre-IPO: Challenges for Mass Adoption Become Clearer
Mirxes files updated prospectus for Hong Kong listing, expanding clinical trial plans but facing challenges in achieving blockbuster-level success.
667 Views
Hong Kong: IPO SPOTLIGHT - OVERVIEW 2025
Hong Kong is the top global destination for IPOs in 2025, with over HK $280 billion raised so far. Large scale A+H dual listings have surged this...
575 Views